Celyad Oncology Stocks Plunge 22%: What’s Behind The Drop?
(VIANEWS) – Celyad Oncology’s (BEL 20: CYAD.BR) shares experienced a dramatic drop of 22.77% to EUR0.36 on Thursday at 14:18 EST, marking an end to five days of consecutive losses for this stock. Meanwhile, BEL 20 index currently trades flat at EUR3,511.130 after showing signs of strength in previous sessions; suggesting this exchange session appears…